BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 18566246)

  • 1. Histone deacetylase inhibitors induce growth arrest, apoptosis, and differentiation in clear cell sarcoma models.
    Liu S; Cheng H; Kwan W; Lubieniecka JM; Nielsen TO
    Mol Cancer Ther; 2008 Jun; 7(6):1751-61. PubMed ID: 18566246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting Histone Deacetylase Activity to Arrest Cell Growth and Promote Neural Differentiation in Ewing Sarcoma.
    Souza BK; da Costa Lopez PL; Menegotto PR; Vieira IA; Kersting N; Abujamra AL; Brunetto AT; Brunetto AL; Gregianin L; de Farias CB; Thiele CJ; Roesler R
    Mol Neurobiol; 2018 Sep; 55(9):7242-7258. PubMed ID: 29397557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Romidepsin (depsipeptide) induced cell cycle arrest, apoptosis and histone hyperacetylation in lung carcinoma cells (A549) are associated with increase in p21 and hypophosphorylated retinoblastoma proteins expression.
    Vinodhkumar R; Song YS; Devaki T
    Biomed Pharmacother; 2008 Feb; 62(2):85-93. PubMed ID: 17644301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histone deacetylase inhibitor, Romidepsin (FK228) inhibits endometrial cancer cell growth through augmentation of p53-p21 pathway.
    Li LH; Zhang PR; Cai PY; Li ZC
    Biomed Pharmacother; 2016 Aug; 82():161-6. PubMed ID: 27470351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MS-27-275, an inhibitor of histone deacetylase, has marked in vitro and in vivo antitumor activity against pediatric solid tumors.
    Jaboin J; Wild J; Hamidi H; Khanna C; Kim CJ; Robey R; Bates SE; Thiele CJ
    Cancer Res; 2002 Nov; 62(21):6108-15. PubMed ID: 12414635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular diagnosis of clear cell sarcoma: detection of EWS-ATF1 and MITF-M transcripts and histopathological and ultrastructural analysis of 12 cases.
    Antonescu CR; Tschernyavsky SJ; Woodruff JM; Jungbluth AA; Brennan MF; Ladanyi M
    J Mol Diagn; 2002 Feb; 4(1):44-52. PubMed ID: 11826187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment of a novel clear cell sarcoma cell line (Hewga-CCS), and investigation of the antitumor effects of pazopanib on Hewga-CCS.
    Outani H; Tanaka T; Wakamatsu T; Imura Y; Hamada K; Araki N; Itoh K; Yoshikawa H; Naka N
    BMC Cancer; 2014 Jun; 14():455. PubMed ID: 24946937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticancer activity of MS-275, a novel histone deacetylase inhibitor, against human endometrial cancer cells.
    Takai N; Ueda T; Nishida M; Nasu K; Narahara H
    Anticancer Res; 2006; 26(2A):939-45. PubMed ID: 16619490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [MS-275, a histone deacetylase inhibitor, induces apoptosis and alters survivin gene expression in human myeloma cell line U266].
    Ma J; Zhao M; Yu XD; Wang ZH
    Ai Zheng; 2009 May; 28(5):466-71. PubMed ID: 19624872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting the EWS-ETS transcriptional program by BET bromodomain inhibition in Ewing sarcoma.
    Hensel T; Giorgi C; Schmidt O; Calzada-Wack J; Neff F; Buch T; Niggli FK; Schäfer BW; Burdach S; Richter GH
    Oncotarget; 2016 Jan; 7(2):1451-63. PubMed ID: 26623725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell-type dependent enhancer binding of the EWS/ATF1 fusion gene in clear cell sarcomas.
    Komura S; Ito K; Ohta S; Ukai T; Kabata M; Itakura F; Semi K; Matsuda Y; Hashimoto K; Shibata H; Sone M; Jo N; Sekiguchi K; Ohno T; Akiyama H; Shimizu K; Woltjen K; Ozawa M; Toguchida J; Yamamoto T; Yamada Y
    Nat Commun; 2019 Sep; 10(1):3999. PubMed ID: 31488818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of histone deacetylase inhibitors on the induction of differentiation in chondrosarcoma cells.
    Sakimura R; Tanaka K; Yamamoto S; Matsunobu T; Li X; Hanada M; Okada T; Nakamura T; Li Y; Iwamoto Y
    Clin Cancer Res; 2007 Jan; 13(1):275-82. PubMed ID: 17200366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histone deacetylase inhibitors induce growth inhibition, cell cycle arrest and apoptosis in human choriocarcinoma cells.
    Takai N; Ueda T; Nishida M; Nasu K; Narahara H
    Int J Mol Med; 2008 Jan; 21(1):109-15. PubMed ID: 18097623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EWS/ATF1 expression induces sarcomas from neural crest-derived cells in mice.
    Yamada K; Ohno T; Aoki H; Semi K; Watanabe A; Moritake H; Shiozawa S; Kunisada T; Kobayashi Y; Toguchida J; Shimizu K; Hara A; Yamada Y
    J Clin Invest; 2013 Feb; 123(2):600-10. PubMed ID: 23281395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel histone deacetylase inhibitors induce growth arrest, apoptosis, and differentiation in sarcoma cancer stem cells.
    Di Pompo G; Salerno M; Rotili D; Valente S; Zwergel C; Avnet S; Lattanzi G; Baldini N; Mai A
    J Med Chem; 2015 May; 58(9):4073-9. PubMed ID: 25905694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CBHA is a family of hybrid polar compounds that inhibit histone deacetylase, and induces growth inhibition, cell cycle arrest and apoptosis in human endometrial and ovarian cancer cells.
    Takai N; Ueda T; Nishida M; Nasu K; Matsuda K; Kusumoto M; Narahara H
    Oncology; 2006; 70(2):97-105. PubMed ID: 16601366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Romidepsin (FK228) and its analogs directly inhibit phosphatidylinositol 3-kinase activity and potently induce apoptosis as histone deacetylase/phosphatidylinositol 3-kinase dual inhibitors.
    Saijo K; Katoh T; Shimodaira H; Oda A; Takahashi O; Ishioka C
    Cancer Sci; 2012 Nov; 103(11):1994-2001. PubMed ID: 22924958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histone deacetylase inhibitors promote osteoblast maturation.
    Schroeder TM; Westendorf JJ
    J Bone Miner Res; 2005 Dec; 20(12):2254-63. PubMed ID: 16294278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The melanocyte inducing factor MITF is stably expressed in cell lines from human clear cell sarcoma.
    Li KK; Goodall J; Goding CR; Liao SK; Wang CH; Lin YC; Hiraga H; Nojima T; Nagashima K; Schaefer KL; Lee KA
    Br J Cancer; 2003 Sep; 89(6):1072-8. PubMed ID: 12966428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel role of HDAC inhibitors in AML1/ETO AML cells: activation of apoptosis and phagocytosis through induction of annexin A1.
    Tabe Y; Jin L; Contractor R; Gold D; Ruvolo P; Radke S; Xu Y; Tsutusmi-Ishii Y; Miyake K; Miyake N; Kondo S; Ohsaka A; Nagaoka I; Andreeff M; Konopleva M
    Cell Death Differ; 2007 Aug; 14(8):1443-56. PubMed ID: 17464329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.